f04-053 Protocolos Farmacéuticos

Embed Size (px)

Citation preview

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    1/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 1

    Validation Protocol P04-053

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    2/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 2

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    3/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 3

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    4/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 4

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    5/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 5

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    6/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 6

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    7/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 7

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    8/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 8

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    9/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 9

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    10/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    11/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 11

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    12/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 12

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    13/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 13

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    14/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 14

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    15/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 15

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    16/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 16

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    17/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 17

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    18/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 18

    Validation Final Report F04-053

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    19/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 19

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    20/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 20

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    21/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 21

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    22/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 22

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    23/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    24/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 24

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    25/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 25

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    26/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 26

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    27/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 27

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    28/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 28

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    29/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 29

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    30/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 30

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    31/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    32/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    33/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    34/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    35/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    36/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 36

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    37/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 37

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    38/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    39/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    40/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    41/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 41

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    42/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 42

    Validation Final Report Addendum F04-053

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    43/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 43

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    44/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 44

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    45/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 45

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    46/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 46

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    47/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 47

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    48/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    49/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    50/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 50

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    51/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 51

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    52/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 52

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    53/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 53

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    54/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 54

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    55/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 55

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    56/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    57/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    58/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 58

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    59/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 59

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    60/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 60

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    61/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    62/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 62

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    63/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 63

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    64/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 64

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    65/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 65

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    66/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 66

    Validation Final Report F04-054

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    67/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 67

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    68/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 68

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    69/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 69

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    70/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 70

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    71/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 71

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    72/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 72

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    73/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 73

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    74/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 74

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    75/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    76/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 76

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    77/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    78/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 78

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    79/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    80/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    81/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    82/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    83/121

    DMFDossierH

    exGRF(1-44),Acetate

    BACHEM,

    Inc.

    3.2.S.4.3

    Document5-ValidationofMethodsfo

    rDeterminationof

    IdentityandPurity

    Version1.0

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    84/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 84

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    85/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 85

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    86/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    87/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 87

    Validation Protocol P08-039

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    88/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 88

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    89/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 89

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    90/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 90

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    91/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 91

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    92/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 92

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    93/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 93

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    94/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 94

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    95/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 95

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    96/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 96

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    97/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 97

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    98/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 98

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    99/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    100/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 100

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    101/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 101

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    102/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 102

    Validation Final Report F08-039

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    103/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 103

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    104/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 104

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    105/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 105

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    106/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 106

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    107/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    108/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 108

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    109/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 109

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    110/121

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    111/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 111

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    112/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 112

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    113/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 113

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    114/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 114

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    115/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 115

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    116/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 116

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    117/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 117

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    118/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 118

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    119/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 119

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    120/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0

    Module 3, Open Part Page 120

  • 8/9/2019 f04-053 Protocolos Farmacuticos

    121/121

    DMF Dossier HexGRF (1-44), Acetate BACHEM, Inc.3.2.S.4.3 Document 5 - Validation of Methods for Determination of

    Identity and Purity Version 1.0